Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;58(6):648-55.
doi: 10.1016/j.neuint.2011.02.003. Epub 2011 Feb 17.

Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis

Affiliations

Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis

Rozzy Finn et al. Neurochem Int. 2011 May.

Abstract

The juvenile onset form of neuronal ceroid lipofuscinoses (JNCL) is a recessively inherited lysosomal storage disorder characterized by progressive neurodegeneration. JNCL results from mutations in the CLN3 gene that encodes a lysosomal membrane protein with unknown function. Utilizing a Cln3-knock-out mouse model of JNCL that was created on the 129S6/SvEv genetic background, we have previously demonstrated that CLN3-deficient cerebellar granule cells (CGCs) have a selectively increased sensitivity to AMPA-type glutamate receptor-mediated toxicity. Our recent findings that CGCs from 129S6/SvEv and C57BL/6J wild type (WT) mice have significant differences in glutamate receptor expression and in excitotoxic vulnerability indicated that the genetic background possibly have a strong influence on how glutamate receptor function is dysregulated in CLN3-deficient neurons. Indeed, here we show that in the Cln3(Δex7/8)-knock-in mouse model, that is on the C57BL/6J genetic background, mimics the most frequent mutation observed in JNCL patients and considered a null mutant, the sensitivity of CGCs to both AMPA- and NMDA-type glutamate receptor overactivations is altered. Cultured wild type and Cln3(Δex7/8) CGCs were equally sensitive to AMPA toxicity after 2 or 3 weeks in vitro, whereas the subunit-selective AMPA receptor agonist, CPW-399, induced significantly more cell death in mature, 3-week-old Cln3(Δex7/8) cultures. NMDA receptor-mediated toxicity changed during in vitro development: Cln3(Δex7/8) CGCs were less sensitive to high concentration of NMDA after 2 weeks in culture but became more vulnerable than their WT counterparts after 3 weeks in vitro. Abnormally altered glutamate receptor function in the cerebellum may result in motor deficits, and we confirmed that 7-week-old Cln3(Δex7/8) mice, similarly to Cln3-knock-out mice, have a motor coordination deficit as measured by an accelerating rotarod. Our results demonstrate altered glutamate receptor function in Cln3(Δex7/8) neurons and suggest that both AMPA and NMDA receptors are potential therapeutic targets in JNCL.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

None of the authors of this paper has any conflict of interest relating to the publication.

Figures

Fig. 1
Fig. 1. Cln3 Δex7-8 and WT cerebellar granule cells have similar sensitivity to AMPA-induced cell death
AMPA-induced cell death was investigated in primary cultures of CGCs prepared from seven-day-old WT (solid bars) and Cln3 Δex7-8 (open bars) mice. Cultures were maintained in Neurobasal medium with B27 serum replacement. On the 14th (A) or 21st (B) day in vitro (DIV14 or DIV21), cultures were exposed to the indicated concentrations of AMPA for two hours in Neurobasal medium without B27. Cyclothiazide (CTZ) was added at a concentration of 100 μM to prevent desensitization of AMPA receptors. Treatments were done in the presence of 50 μM MK-801 to prevent transactivation of NMDA receptors. Upon completion of the two-hour treatment, medium was replaced with complete, B27-containing Neurobasal medium. Cell viability was determined using the MTT viability assay twenty-four hours later. Results presented here represent mean ± S.E.M. of four separate culture preparations (n = 9–22). No statistically significant differences between WT and Cln3 Δex7-8 cultures were found by two-way ANOVA with Bonferroni’s post-test for multiple comparisons.
Fig. 2
Fig. 2. Cln3 Δex7-8 cerebellar granule cells are significantly more sensitive to the subtype-selective AMPA receptor agonist, CPW-399, in mature, three-week-old cultures
CPW-399-induced cell death was investigated in primary cultures of CGC prepared from seven-day-old WT (solid bars) and Cln3 Δex7-8 (open bars) mice. Cultures were maintained in Neurobasal medium with B27 serum replacement. On the 14th (A) or 21st (B) day in vitro (DIV14 or DIV21), cultures were exposed to the indicated concentrations of CPW-399 for two hours in Neurobasal medium without B27. CPW-399 is a non-desensitizing, subtype-selective AMPA receptor agonist. Treatments were done in the presence of 50 μM MK-801 to prevent transactivation of NMDA receptors. Upon completion of the two-hour treatment, medium was replaced with complete, B27-containing Neurobasal medium. Cell viability was determined using the MTT viability assay twenty-four hours later. Results presented here represent mean ± S.E.M. of four separate culture preparations (n = 8–22). Statistical significance was determined by two-way ANOVA with Bonferroni’s post-test for multiple comparisons: * p<0.05, *** p<0.001.
Fig. 3
Fig. 3. Relative sensitivity of Cln3 Δex7-8 cerebellar granule cells to NMDA receptor-mediated toxicity changes during in vitro development
NMDA receptor-mediated cell death was investigated in primary cultures of CGC prepared from seven-day-old WT (solid bars) and Cln3 Δex7-8 (open bars) mice. Cultures were maintained in Neurobasal medium with B27 serum replacement. On the 14th (A) or 21st (B) day in vitro (DIV14 or DIV21), cultures were exposed to the indicated concentrations of NMDA for two hours in Neurobasal medium without B27. Upon completion of the two-hour treatment, medium was replaced with complete, B27-containing Neurobasal medium. Cell viability was determined using the MTT viability assay twenty-four hours later. Results presented here represent mean ± S.E.M. of four separate culture preparations (n = 11–19). Statistical significance was determined by two-way ANOVA with Bonferroni’s post-test for multiple comparisons: ** p<0.01, *** p<0.001.
Fig. 4
Fig. 4. Surface/Total ratio of the GluR1 AMPA receptor subunit is significantly higher in the cerebellum of one-month-old Cln3 Δex7-8 mice
Surface and intracellular expression levels of the GluR1, GluR2, and GluR4 AMPA receptor subunits were investigated using acutely isolated slices from the cerebella of one-month-old WT (solid bars) and Cln3 Δex7-8 (open bars) mice. Slices were subjected to surface cross-linking and then analyzed by Western blot for GluR1, GluR2, and GluR4. A: Western blots showing separation of surface (cross-linked) and intracellular receptor subunits. B-D: Quantification of surface, intracellular, and total (surface + intracellular) subunit expression levels. E-G: Comparison of relative surface/total subunit expression ratios. For graphs B-G, Subunit expression levels were normalized to total protein as determined by Ponceau S staining. All measurements for Cln3 Δex7-8 samples are expressed as a percentage of WT. Four mice were analyzed for each genotype; histogram bars represent mean ± S.E.M. Statistical significance was determined by two-way ANOVA with Bonferroni’s post-test for multiple comparisons (B-D) or unpaired t-test (E-G), * p<0.05.
Fig. 5
Fig. 5. Expression levels of the NR1, NR2A and NR2B NMDA receptor subunits in the cerebellum of one-month-old Cln3 Δex7-8 and WT mice
Surface and intracellular expression levels of the NR1, NR2A, and NR2B NMDA receptor subunits were investigated using acutely isolated slices from the cerebella of one-month-old WT (solid bars) and Cln3 Δex7-8 (open bars) mice. Slices were subjected to surface cross-linking and then analyzed by Western blot for NR1, NR2A, and NR2B. A: Western blots showing separation of surface (cross-linked) and intracellular receptor subunits. B-D: Quantification of surface, intracellular, and total (surface + intracellular) subunit expression levels. E-G: Comparison of relative surface/total subunit expression ratios. For graphs B-G, Subunit expression levels were normalized to total protein as determined by Ponceau S staining. All measurements for Cln3 Δex7-8 samples are expressed as a percentage of WT. Four mice were analyzed for each genotype; histogram bars represent mean ± S.E.M. Statistical significance was determined by two-way ANOVA with Bonferroni’s post-test for multiple comparisons (B-D) or unpaired t-test (E-G).
Fig. 6
Fig. 6. Cln3 Δex7/8 mice have a motor coordination deficit
An accelerating rotarod (from 0 to 37 rpm in 120 s) was used to measure the motor skills of 7-week-old WT and Cln3 Δex7-8 male mice. Data are plotted as the time at which animals fell from the rotarod. Cln3 Δex7/8 mice had a reduced ability to remain on the rod as it accelerated. Columns and bars represent mean ± S.E.M. (n = 12). The data sets passed the normality test (α level 0.05), and therefore, statistical significance was determined by unpaired t-test.

References

    1. Adams HR, Beck CA, Levy E, Jordan R, Kwon JM, Marshall FJ, Vierhile A, Augustine EF, de Blieck EA, Pearce DA, Mink JW. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease) Dev Med Child Neurol. 2010;52:637–643. - PMC - PubMed
    1. Bilovocky NA, Romito-DiGiacomo RR, Murcia CL, Maricich SM, Herrup K. Factors in the genetic background suppress the engrailed-1 cerebellar phenotype. J Neurosci. 2003;23:5105–5112. - PMC - PubMed
    1. Boudreau AC, Wolf ME. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci. 2005;25:9144–9151. - PMC - PubMed
    1. Bowie D. Ionotropic glutamate receptors & CNS disorders. CNS Neurol Disord Drug Targets. 2008;7:129–143. - PMC - PubMed
    1. Campiani G, Morelli E, Nacci V, Fattorusso C, Ramunno A, Novellino E, Greenwood J, Liljefors T, Griffiths R, Sinclair C, Reavy H, Kristensen AS, Pickering DS, Schousboe A, Cagnotto A, Fumagalli E, Mennini T. Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. J Med Chem. 2001;44:4501–4504. - PubMed

Publication types

MeSH terms